All depts achieve 100 per cent target under disease control drive
Varanasi: The special
communicable disease control campaign
was successfully conducted from April 1 to April 30 with all departments achieving nearly 100 per cent of their targets.
During the
Dastak campaign
, the
health department
surveyed approximately 7 lakh households.
Individuals with symptoms of fever and
influenza-like illness
(cold, cough, flu) were screened. Additionally, community and self-help group meetings, and public awareness rallies were organised.
District malaria officer Sharad Chand Pandey said under the communicable disease control campaign, Dastak campaign was conducted from April 10 to April 30. Asha and Anganwadi workers identified 2,091 fever cases and 496 ILI (influenza-like illness) patients by visiting households.
Under the Dastak campaign,
Asha workers
identified 697 individuals with malaria symptoms, 496 with cold and fever, 35 with TB symptoms, 39 with filariasis symptoms, and 4 with leprosy symptoms. All were examined and treated.
A total of 2,516 drains were cleaned, and 1,439 bushes were cut. Additionally, 308 India Mark-2 hand pumps and 126 platforms were repaired. 110 ponds and 145 areas with stagnant water were cleaned. The
Swachh Bharat Mission
constructed 569 toilets.
Chief Medical Officer (CMO) Dr Sandeep Chaudhary urged people to maintain cleanliness around their homes round the year.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
News18
35 minutes ago
- News18
No 2020-Like Repeat Of Covid-19, Influenza A Bigger Risk: Ex-WHO Scientist Soumya Swaminathan
Last Updated: Addressing fears of another catastrophic wave, Swaminathan said periodic surges—roughly every 6-8 months—are expected, largely manageable, and low in severity Influenza, and not Covid-19, likely claims more lives each year in India and globally despite the latter dominating headlines, Dr Soumya Swaminathan, former chief scientist at the World Health Organization (WHO), has told News18. One of the leading experts on infectious diseases, Swaminathan has reassured the public that there is 'absolutely no need to panic now". In an exclusive interview, Swaminathan told News18 that the SARS coronavirus, much like influenza, is now part of the respiratory viruses regularly circulating in the population. ' COVID or SARS-CoV-2, which is the virus, is another respiratory virus, like the many others that are circulating amongst us human beings in the world today. It has been around for five years now. It's, of course, constantly mutating and changing, like other viruses," she said. When asked whether there's a possibility of another 'Delta-like' wave making a return, she said the public needs to understand 'very clearly" that 'we will not see the repeat of 2020 or 2021. At that time, human beings had never seen this virus before". According to her, these periodic surges—roughly every 6-8 months—are expected and largely manageable. 'We have also now started seeing that periodically…There is a rise in circulating Covid-19 cases," she noted, citing data from the Indian Council of Medical Research (ICMR), which indicates that the Omicron variant JN.1 has recently become the dominant strain. Swaminathan, before her ground-breaking role at WHO, was the Director General of the Indian Council of Medical Research (ICMR) and secretary of the Department of Health Research in India. She, however, says that despite the increase in cases, the severity remains low. 'What you're seeing now is a mild disease mostly. Even though people are testing and reporting positivity, you find that hospitalisations are rare," she said. Swaminathan highlighted that individuals with underlying health conditions should continue to take precautions. 'People who have underlying illnesses… are likely to get a little sicker when they get a respiratory infection," she warned, adding that this applies to both Covid-19 and influenza. The flu virus may pose a greater threat than Covid-19. 'Influenza probably kills a lot more people in India and around the world… it makes a lot of sense for vulnerable people to take the flu vaccine, which gets updated every year." Addressing fears of another catastrophic wave, she assured the public: 'It will not happen that we will have a repeat of 2020 or 2021… Today, the virus cannot spread in the same way because it is met with a strong immune response." Do we need booster shots or updated vaccines? According to Swaminathan, there is a need to evaluate the efficacy and cost-effectiveness of updating vaccines, especially in countries like India. 'We see that illness is mild, not requiring hospitalisation… There doesn't seem to be any reason to start a booster campaign now," she said, although she acknowledged the importance of preparing for potential future variants through continued research and updated vaccine development. She also outlined five key areas for pandemic preparedness. 'We need new legislation today that will cover biological threats like pandemics," she said, adding that 'India should have its own list of priority pathogens… and mechanisms for developing vaccines and therapeutics". Also, she said: 'Every state must have a public health cadre… It's essential to deal with so many health risks today, along with the improvement of health literacy and public engagement, which is critical." What should you do? 'Let's take sensible precautions… I see people travelling in crowded buses, trains, and planes, coughing and sneezing without a mask—that's just spreading infection." As for concerns about waning immunity, she explained, 'There are two kinds of immunity… antibodies, which decline over time, and T-cells, which have memory. The moment you are exposed again to the same virus… your immune system does its job." She emphasised that Covid-19 is now an endemic part of life. While vigilance and preparedness are necessary, panic is not. 'We can rest assured now… I would say, let's take sensible precautions… but there's no need for any panic." Watch India Pakistan Breaking News on CNN-News18. Get breaking news, in-depth analysis, and expert perspectives on everything from politics to crime and society. Stay informed with the latest India news only on News18. Download the News18 App to stay updated! First Published:
Time of India
10 hours ago
- Time of India
Beware of common & silent non-alcoholic liver disease
Bhopal: Non-alcoholic fatty liver disease can be a silent disease that shows few or no symptoms but can escalate to serious liver damage. It is a common ailment as well, one that you should be beware of. A state-wide initiative for non-alcoholic fatty liver disease screening began from June 1, including in Bhopal, targeting citizens aged above 30 years. According to a press release, this initiative focuses on awareness, early detection, treatment and prevention of liver-related ailments. The govt of Madhya Pradesh has established a partnership with the Institute of Liver and Biliary Sciences, New Delhi through an MoU. Earlier on May 21, the governor and the chief minister officially inaugurated this campaign on May 21. The programme involves initial screening by Asha workers for suspected NAFLD cases. They will collect data on BMI exceeding 23, waist circumference surpassing 80 cm in women and 90 cm in men, and diabetes history. Suspected cases will be reported to community health officers and workers. Participants will receive guidance on consuming home-available nutritious food and avoiding alcohol and tobacco, with regular follow-ups. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Encontre voos low-cost Voos | Anúncios de Pesquisa Saiba Mais Undo Medical professionals will conduct platelet count, SGOT (AST), SGPT (ALT) tests based on FIB-4 score calculations, followed by FIBROSCAN when medically indicated. Chief medical and health officer (CMHO) Bhopal, Dr Prabhakar Tiwari, emphasised that regular check-ups for non-communicable diseases can reduce illness severity. The non-communicable disease control programme and viral hepatitis control programme offer free services for liver-related issues. Previously, the Nirogi Kaya Abhiyan campaign screened for various non-communicable diseases, including high blood pressure, diabetes, cancer and non-alcoholic fatty liver disease, reaching over 50,000 people. Field health workers received training about liver function, related issues, symptom identification, dietary advice, exercise recommendations, lifestyle guidance and BMI calculations. The liver performs crucial functions continuously, including blood purification, toxin removal, nutrient storage, energy regulation, blood clotting maintenance, and production of bile, proteins, vitamins and minerals. Common liver conditions include fatty liver, fibrosis, hepatitis, cirrhosis and liver cancer.
Time of India
11 hours ago
- Time of India
Respiratory device by AIIMS-R nursing officer gets patent
Raipur: Arokiaraj U, a senior nursing officer in the department of cardiothoracic and vascular surgery (CTVS) at AIIMS-Raipur, has developed a respiratory device to curb the spread of air-borne infections during medical procedures. The Indian Patent Office in New Delhi granted a utility patent for the device. Named 'Highly Oxygenated Aerosol Controlled (HOAC) Combo', it is a closed-system respiratory support unit designed to reduce the risk of airborne infections during nebulization, sputum sampling, incentive spirometry, and low-flow oxygen therapy. It offers protection to both patients and healthcare workers. The HOAC device is currently in the functional prototype development phase, with efforts underway to secure funding. This will be followed by pilot studies and clinical validation, paving the way for its large-scale implementation in India and globally. Arokiaraj U showcased this device at the India Innovation Summit 2025, held on March 18–19 at Bharat Mandapam Convention Centre, New Delhi. The Department of Health Research (DHR) and the Indian Council of Medical Research (ICMR) organised the summit. The device has also been published on the ATLAS of Innovation platform, a research platform supporting the development of new technologies for TB elimination. Lt. Gen. Ashok Jindal (Retd), executive director and CEO of AIIMS-Raipur, congratulated Arokiaraj, calling the development a significant achievement for AIIMS-Raipur. AIIMS-Raipur nominated Arokiaraj for the National Florence Nightingale Award and the National Science Award 2025 in recognition of his contribution. Arokiaraj expressed gratitude to the medical superintendent, the CTVS department, and the AIIMS-Raipur administration for their support and guidance.
